Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
VIMIZIM192.52M29.67%
VOXZOGO152.89M23.56%
NAGLAZYME105.63M16.28%
PALYNZIQ75.71M11.67%
BRINEURA39.05M6.02%
KUVAN35.91M5.53%
ALDURAZYME35.26M5.43%
Royalty and other revenues11.02M1.70%
ROCTAVIAN849K0.13%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States771.31M31.88%
Europe669.33M27.67%
Rest of World468.21M19.35%
Latin America332.44M13.74%
ALDURAZYME net product revenues marketed by Sanofi131.25M5.43%
Royalty and other revenues46.69M1.93%
View all
